In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model (Q42627381)

From Wikidata
Jump to navigation Jump to search
scientific article published on 25 June 2007
edit
Language Label Description Also known as
English
In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model
scientific article published on 25 June 2007

    Statements

    In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model (English)
    1 reference
    Jocelyne Caillon
    1 reference
    Virginie Le Mabecque
    1 reference
    Anne-Françoise Miègeville
    1 reference
    Antoine Hamel
    1 reference
    Denis Bugnon
    1 reference
    James Yigong Ge
    1 reference
    Gilles Potel
    1 reference
    25 June 2007
    1 reference
    51
    1 reference
    3397-3400
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit